T1	Disorder 6 19	liver failure
N1 	Reference T1 UMLS:C0085605	liver failure
T2	Pharmacological_substance 77 88	montelukast
N1000 	Reference T2 MeSH:C093875	montelukast
T5	Disorder 270 275	death
N2 	Reference T5 UMLS:C1306577	death
T6	Pharmacological_substance 291 302	paracetamol
N1001 	Reference T6 MeSH:D000082	paracetamol
T7	Disorder 308 318	alcoholism
N3 	Reference T7 UMLS:C0001973	alcoholism
T8	Disorder 324 340	Wilson's disease
N4 	Reference T8 UMLS:C0019202	Wilson's disease
T9	Disorder 389 395	asthma
N5 	Reference T9 UMLS:C0004096	asthma
T10	Pharmacological_substance 422 453	leukotriene receptor antagonist
N1002 	Reference T10 MeSH:D020024	leukotriene receptor antagonist
T11	Disorder 695 704	hepatitis
N6 	Reference T11 UMLS:C0019158	hepatitis
T12	Disorder 904 913	hepatitis
N7 	Reference T12 UMLS:C0019158	hepatitis
T13	Disorder 1016 1027	hepatotoxic
N8 	Reference T13 UMLS:C0274591	hepatotoxic
N9 	Reference T13 UMLS:C0019193	hepatotoxic
N10 	Reference T13 UMLS:C0019193	hepatotoxic
N11 	Reference T13 UMLS:C0274591	hepatotoxic
T14	Pharmacological_substance 455 466	montelukast
N1003 	Reference T14 MeSH:C093875	montelukast
T15	Subject 216 239	45-year-old obese woman
T17	Disorder 186 206	parenchymal collapse
T18	Disorder 90 112	High aminotransferases
N12 	Reference T18 UMLS:C0438717	High aminotransferases
T19	Disorder 117 143	prolonged prothrombin time
N13 	Reference T19 UMLS:C0151872	prolonged prothrombin time
T20	Disorder 277 289	Autoimmunity
N14 	Reference T20 UMLS:C0004368	Autoimmunity
T24	Pharmacological_substance 963 974	montelukast
N1004 	Reference T24 MeSH:C093875	montelukast
